iShares Genomics Immunology and Healthcare ETF
BlackRock, Inc. IDNA ETF
| IDNA Price | $22.9 |
Market Cap | $112.38M |
| Annual Dividend Yield | 1.15% |
Annual Dividend | $0.26 |
| Yearly Management Fee | 0.47% |
Asset Class | Equity |
| Focus | Theme |
Category | Sector, Theme |
| Niche | Genomic advancements |
Last 24h Volume | $15.67K |
| Portfolio Management Company | BlackRock, Inc. |
Discount/Premium to NAV | 0.14% |
| Inception Date | Jun 11, 2019 |
Market Cap Rank | 2177 |
| Monthly AUM Growth | 2.27% |
Holdings Region | Global |
| Management Style | Passive |
Leverage | Non-Leveraged |
iShares Genomics Immunology and Healthcare ETF is an ETF issued by BlackRock, Inc. on Jun 11 2019.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Theme".
As of today, the price of IDNA ETF according to its net asset value is premiumed at 0.14%.
While the total value of the fund shows $2.5M increase compared to the previous month, its price is traded daily at a increase of 0.09%.
The annual dividend yield of IDNA ETF is 1.15%, whereas its main asset area is Global.
IDNA ETF, whose 24-hour total volume is $15.67K, has experienced a $-3,175,935 cash outflow in the last month.
In addition, iShares Genomics Immunology and Healthcare ETF's 3-month net asset value total return is 16.47%.
IDNA ETF Returns
| Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
| 0.09% |
8.33% |
6.07% |
13.99% |
0.13% |
0.66% |
-5.80% |
IDNA ETF NAV Total Return
| Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
| 9.04% |
16.47% |
1.82% |
-3.12% |
-27.39% |
-37.07% |
IDNA ETF Fund Flows Chart
IDNA ETF Market Cap Chart
IDNA ETF NAV Growth Chart
IDNA ETF Comments
no comments yet